Abstract
Summary
Monoammonium glycyrrhizinate has hormone like activity, but has no side effects of hormone. It not only has significant curative effects on respiratory diseases such as tracheitis, bronchitis, cough, asthma, but also has marvelous effects on digestive tract infection, hepatitis B, oral ulcer and gastric ulcer. It has strong detoxification effects on many kinds of toxins, such as diphtheria toxin, rapacian toxin, tetanus toxin and snake venom. At the same time, it also has the similar effect of adrenocortical hormone.
The global Pharmaceutical Grade Monoammonium Glycyrrhizinate market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade Monoammonium Glycyrrhizinate Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Monoammonium Glycyrrhizinate sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Monoammonium Glycyrrhizinate sales for 2024 through 2030. With Pharmaceutical Grade Monoammonium Glycyrrhizinate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Monoammonium Glycyrrhizinate industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Monoammonium Glycyrrhizinate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Monoammonium Glycyrrhizinate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Monoammonium Glycyrrhizinate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Monoammonium Glycyrrhizinate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Monoammonium Glycyrrhizinate.
United States market for Pharmaceutical Grade Monoammonium Glycyrrhizinate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharmaceutical Grade Monoammonium Glycyrrhizinate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharmaceutical Grade Monoammonium Glycyrrhizinate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharmaceutical Grade Monoammonium Glycyrrhizinate players cover VITAL-CHEM Zhuhai, Sabinsa, Alchem International, Shaanxi Fujie Pharmaceutical and MAFCO Worldwide, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Monoammonium Glycyrrhizinate market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Purity ≥99%
Purity ＜99%
Segmentation by application
Injection
Tablet
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
VITAL-CHEM Zhuhai
Sabinsa
Alchem International
Shaanxi Fujie Pharmaceutical
MAFCO Worldwide
Alps Pharmaceutical
BGG World
Qingdao Taitong Pharmaceutical
Cokey
Jiangsu Tiansheng Pharmaceutical
Shaanxi Jintai Biological Engineering
Qinghai Lake Pharmaceutical
Gansu Sandi
Fanzhi Pharmaceutical
Longtong Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Grade Monoammonium Glycyrrhizinate market?
What factors are driving Pharmaceutical Grade Monoammonium Glycyrrhizinate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade Monoammonium Glycyrrhizinate market opportunities vary by end market size?
How does Pharmaceutical Grade Monoammonium Glycyrrhizinate break out type, application?
The global Pharmaceutical Grade Monoammonium Glycyrrhizinate market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade Monoammonium Glycyrrhizinate Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Monoammonium Glycyrrhizinate sales in 2023, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Monoammonium Glycyrrhizinate sales for 2024 through 2030. With Pharmaceutical Grade Monoammonium Glycyrrhizinate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Monoammonium Glycyrrhizinate industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Monoammonium Glycyrrhizinate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Monoammonium Glycyrrhizinate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Monoammonium Glycyrrhizinate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Monoammonium Glycyrrhizinate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Monoammonium Glycyrrhizinate.
United States market for Pharmaceutical Grade Monoammonium Glycyrrhizinate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Pharmaceutical Grade Monoammonium Glycyrrhizinate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Pharmaceutical Grade Monoammonium Glycyrrhizinate is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Pharmaceutical Grade Monoammonium Glycyrrhizinate players cover VITAL-CHEM Zhuhai, Sabinsa, Alchem International, Shaanxi Fujie Pharmaceutical and MAFCO Worldwide, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Monoammonium Glycyrrhizinate market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
Purity ≥99%
Purity ＜99%
Segmentation by application
Injection
Tablet
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
VITAL-CHEM Zhuhai
Sabinsa
Alchem International
Shaanxi Fujie Pharmaceutical
MAFCO Worldwide
Alps Pharmaceutical
BGG World
Qingdao Taitong Pharmaceutical
Cokey
Jiangsu Tiansheng Pharmaceutical
Shaanxi Jintai Biological Engineering
Qinghai Lake Pharmaceutical
Gansu Sandi
Fanzhi Pharmaceutical
Longtong Pharma
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Grade Monoammonium Glycyrrhizinate market?
What factors are driving Pharmaceutical Grade Monoammonium Glycyrrhizinate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Grade Monoammonium Glycyrrhizinate market opportunities vary by end market size?
How does Pharmaceutical Grade Monoammonium Glycyrrhizinate break out type, application?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Pharmaceutical Grade Monoammonium Glycyrrhizinate by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Pharmaceutical Grade Monoammonium Glycyrrhizinate by Country/Region, 2019, 2023 & 2030
2.2 Pharmaceutical Grade Monoammonium Glycyrrhizinate Segment by Type
2.2.1 Purity ≥99%
2.2.2 Purity ＜99%
2.3 Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Type
2.3.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales Market Share by Type (2019-2024)
2.3.2 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Revenue and Market Share by Type (2019-2024)
2.3.3 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Sale Price by Type (2019-2024)
2.4 Pharmaceutical Grade Monoammonium Glycyrrhizinate Segment by Application
2.4.1 Injection
2.4.2 Tablet
2.4.3 Others
2.5 Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Application
2.5.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Sale Market Share by Application (2019-2024)
2.5.2 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Revenue and Market Share by Application (2019-2024)
2.5.3 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Sale Price by Application (2019-2024)
3 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate by Company
3.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Breakdown Data by Company
3.1.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Annual Sales by Company (2019-2024)
3.1.2 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales Market Share by Company (2019-2024)
3.2 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Annual Revenue by Company (2019-2024)
3.2.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Revenue by Company (2019-2024)
3.2.2 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Revenue Market Share by Company (2019-2024)
3.3 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Grade Monoammonium Glycyrrhizinate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Location Distribution
3.4.2 Players Pharmaceutical Grade Monoammonium Glycyrrhizinate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pharmaceutical Grade Monoammonium Glycyrrhizinate by Geographic Region
4.1 World Historic Pharmaceutical Grade Monoammonium Glycyrrhizinate Market Size by Geographic Region (2019-2024)
4.1.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Pharmaceutical Grade Monoammonium Glycyrrhizinate Market Size by Country/Region (2019-2024)
4.2.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Annual Sales by Country/Region (2019-2024)
4.2.2 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Annual Revenue by Country/Region (2019-2024)
4.3 Americas Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales Growth
4.4 APAC Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales Growth
4.5 Europe Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales Growth
4.6 Middle East & Africa Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales Growth
5 Americas
5.1 Americas Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Country
5.1.1 Americas Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Country (2019-2024)
5.1.2 Americas Pharmaceutical Grade Monoammonium Glycyrrhizinate Revenue by Country (2019-2024)
5.2 Americas Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Type
5.3 Americas Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Region
6.1.1 APAC Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Region (2019-2024)
6.1.2 APAC Pharmaceutical Grade Monoammonium Glycyrrhizinate Revenue by Region (2019-2024)
6.2 APAC Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Type
6.3 APAC Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Grade Monoammonium Glycyrrhizinate by Country
7.1.1 Europe Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Country (2019-2024)
7.1.2 Europe Pharmaceutical Grade Monoammonium Glycyrrhizinate Revenue by Country (2019-2024)
7.2 Europe Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Type
7.3 Europe Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Grade Monoammonium Glycyrrhizinate by Country
8.1.1 Middle East & Africa Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Country (2019-2024)
8.1.2 Middle East & Africa Pharmaceutical Grade Monoammonium Glycyrrhizinate Revenue by Country (2019-2024)
8.2 Middle East & Africa Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Type
8.3 Middle East & Africa Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Grade Monoammonium Glycyrrhizinate
10.3 Manufacturing Process Analysis of Pharmaceutical Grade Monoammonium Glycyrrhizinate
10.4 Industry Chain Structure of Pharmaceutical Grade Monoammonium Glycyrrhizinate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Grade Monoammonium Glycyrrhizinate Distributors
11.3 Pharmaceutical Grade Monoammonium Glycyrrhizinate Customer
12 World Forecast Review for Pharmaceutical Grade Monoammonium Glycyrrhizinate by Geographic Region
12.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Market Size Forecast by Region
12.1.1 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Forecast by Region (2025-2030)
12.1.2 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Forecast by Type
12.7 Global Pharmaceutical Grade Monoammonium Glycyrrhizinate Forecast by Application
13 Key Players Analysis
13.1 VITAL-CHEM Zhuhai
13.1.1 VITAL-CHEM Zhuhai Company Information
13.1.2 VITAL-CHEM Zhuhai Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.1.3 VITAL-CHEM Zhuhai Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 VITAL-CHEM Zhuhai Main Business Overview
13.1.5 VITAL-CHEM Zhuhai Latest Developments
13.2 Sabinsa
13.2.1 Sabinsa Company Information
13.2.2 Sabinsa Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.2.3 Sabinsa Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Sabinsa Main Business Overview
13.2.5 Sabinsa Latest Developments
13.3 Alchem International
13.3.1 Alchem International Company Information
13.3.2 Alchem International Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.3.3 Alchem International Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Alchem International Main Business Overview
13.3.5 Alchem International Latest Developments
13.4 Shaanxi Fujie Pharmaceutical
13.4.1 Shaanxi Fujie Pharmaceutical Company Information
13.4.2 Shaanxi Fujie Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.4.3 Shaanxi Fujie Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Shaanxi Fujie Pharmaceutical Main Business Overview
13.4.5 Shaanxi Fujie Pharmaceutical Latest Developments
13.5 MAFCO Worldwide
13.5.1 MAFCO Worldwide Company Information
13.5.2 MAFCO Worldwide Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.5.3 MAFCO Worldwide Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 MAFCO Worldwide Main Business Overview
13.5.5 MAFCO Worldwide Latest Developments
13.6 Alps Pharmaceutical
13.6.1 Alps Pharmaceutical Company Information
13.6.2 Alps Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.6.3 Alps Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Alps Pharmaceutical Main Business Overview
13.6.5 Alps Pharmaceutical Latest Developments
13.7 BGG World
13.7.1 BGG World Company Information
13.7.2 BGG World Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.7.3 BGG World Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 BGG World Main Business Overview
13.7.5 BGG World Latest Developments
13.8 Qingdao Taitong Pharmaceutical
13.8.1 Qingdao Taitong Pharmaceutical Company Information
13.8.2 Qingdao Taitong Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.8.3 Qingdao Taitong Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Qingdao Taitong Pharmaceutical Main Business Overview
13.8.5 Qingdao Taitong Pharmaceutical Latest Developments
13.9 Cokey
13.9.1 Cokey Company Information
13.9.2 Cokey Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.9.3 Cokey Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Cokey Main Business Overview
13.9.5 Cokey Latest Developments
13.10 Jiangsu Tiansheng Pharmaceutical
13.10.1 Jiangsu Tiansheng Pharmaceutical Company Information
13.10.2 Jiangsu Tiansheng Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.10.3 Jiangsu Tiansheng Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Jiangsu Tiansheng Pharmaceutical Main Business Overview
13.10.5 Jiangsu Tiansheng Pharmaceutical Latest Developments
13.11 Shaanxi Jintai Biological Engineering
13.11.1 Shaanxi Jintai Biological Engineering Company Information
13.11.2 Shaanxi Jintai Biological Engineering Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.11.3 Shaanxi Jintai Biological Engineering Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shaanxi Jintai Biological Engineering Main Business Overview
13.11.5 Shaanxi Jintai Biological Engineering Latest Developments
13.12 Qinghai Lake Pharmaceutical
13.12.1 Qinghai Lake Pharmaceutical Company Information
13.12.2 Qinghai Lake Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.12.3 Qinghai Lake Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Qinghai Lake Pharmaceutical Main Business Overview
13.12.5 Qinghai Lake Pharmaceutical Latest Developments
13.13 Gansu Sandi
13.13.1 Gansu Sandi Company Information
13.13.2 Gansu Sandi Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.13.3 Gansu Sandi Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Gansu Sandi Main Business Overview
13.13.5 Gansu Sandi Latest Developments
13.14 Fanzhi Pharmaceutical
13.14.1 Fanzhi Pharmaceutical Company Information
13.14.2 Fanzhi Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.14.3 Fanzhi Pharmaceutical Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Fanzhi Pharmaceutical Main Business Overview
13.14.5 Fanzhi Pharmaceutical Latest Developments
13.15 Longtong Pharma
13.15.1 Longtong Pharma Company Information
13.15.2 Longtong Pharma Pharmaceutical Grade Monoammonium Glycyrrhizinate Product Portfolios and Specifications
13.15.3 Longtong Pharma Pharmaceutical Grade Monoammonium Glycyrrhizinate Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Longtong Pharma Main Business Overview
13.15.5 Longtong Pharma Latest Developments
14 Research Findings and Conclusion